Journal
ENDOCRINE-RELATED CANCER
Volume 19, Issue 5, Pages F27-F45Publisher
BIOSCIENTIFICA LTD
DOI: 10.1530/ERC-11-0374
Keywords
-
Categories
Ask authors/readers for more resources
Epidemiological studies suggest a positive association between obesity and type 2 diabetes mellitus (T2D) with the risk of cancer and cancer-related mortality. Insulin resistance, hyperinsulinemia, increased levels of IGF, elevated levels of steroid and peptide hormones, and inflammatory markers appear to play a role in the connection between these different diseases. Medications, such as metformin and exogenous insulin, used to treat T2D may affect the risk of cancer and cancer-related mortality. Newer therapies targeting the insulin and IGF1 systems are being developed for use in cancer therapy. Endocrine-Related Cancer (2012) 19 F27-F45
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available